GSK has announced that the FDA has accepted its application to review a prefilled syringe version of Shingrix, its shingles vaccine. This new ver ...

The 30th edition of the Dubai International Pharmaceuticals and Technologies Conference and Exhibition - DUPHAT 2025 concluded successfully, recording AED9.35 billion in direct and indirect trade ...

Starting later this year, Ouro intends to start a phase 1 clinical trial of its own, eyeing the development of the drug for ...

View the full release here: "I'm excited to welcome Alastair to Chemify to help us with building and scaling our ability to ...

Oral Care Hydroxyapatite Market Dental caries, commonly known as tooth decay, is a major oral <a target=_blank href= ...

Portfolio Receipts expected to be approximately $2,800 million, at the upper end of guidance rangeExciting development-stage pipeline with ...

Royalty Pharma plc to become an integrated company by acquiring its external manager, RP Management, LLCSignificant annual cash savings of ...

Germany's biologics market, the largest in Europe, is expected to grow at a 3.8% CAGR from 2025 to 2035. AI is driving this growth by enhancing R&D, optimizing drug design, and identifying novel ...

Alzhemier’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today with ...

Find insight on Zydus Lifesciences, Biotech and more in the latest Market Talks covering the Health Care sector.

Shingrix in 2017 received US FDA approval to prevent shingles in adults aged 50 and older. Since 2021, it has been approved for use in immunocompromised patients aged 18 and up. GSK estimates around ...